Početna › Psorijaza › Michigan
Kliničke studije za Psorijaza u državi Michigan
4 studija za Psorijaza traži sudionike na lokacijama u državi Michigan.
Službeni tekst studije (engleski)
A 16-week Trial to Investigate the Efficacy and Safety of Delgocitinib Cream 20 mg/g in Adult Participants With Mild to Severe Palmoplantar Pustulosis
- LEO Pharma Investigational Site, West Bloomfield
U tijeku regrutacijaFaza 2
Od 18 godina i više · Oba spola · Ažurirano 1. lis 2026. · NCT07013201A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)
- David Fivenson, MD, PLC, Ann Arbor
- The Derm Institute of West Michigan, Caledonia
U tijeku regrutacijaFaza 4
Od 18 godina i više · Oba spola · Ažurirano 4. ruj 2026. · NCT06857942A Study to Evaluate the Efficacy, Safety, and Drug Levels of Deucravacitinib (BMS-986165) in Adolescent Participants With Moderate to Severe Plaque Psoriasis
- C.S. Mott Clinical Research Center (CRC), Detroit
- Henry Ford Medical Center, Detroit
U tijeku regrutacijaFaza 3
Od 12 do 17 godina · Oba spola · Ažurirano 3. ruj 2026. · NCT06979453A Study to Evaluate the Efficacy and Safety of Bimekizumab in Study Participants With Palmoplantar Pustulosis
- Ppp001 50757, Auburn Hills
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 27. kol 2026. · NCT07219420Iz ClinicalTrials.gov, podaci preuzeti 4. lis 2026.. Svaka studija ima svoje uvjete prihoda; tim studije odlučuje tko se može priključiti.